The Republic of Indonesia has announced a pledge of 30 million dollars in support of Gavi, the Vaccine Alliance’s efforts to raise donor funding for its global immunisation efforts from 2026 to 2030.
The new pledge from a former Gavi-implementing country marks the first contribution by a middle-income country towards Gavi’s next strategic period, Gavi 6.0, and it is a testament to the impact of the Alliance’s focus on partnering with countries towards self-sustaining immunisation systems. The contribution also underscores Indonesia’s global health leadership and championing of the critical role vaccines play in building healthier, safer and more prosperous communities worldwide.
Indonesia’s immunisation story is one of transformation and progress. Over 22 years of partnership with Gavi, the country has doubled the number of vaccines offered through its routine immunisation programme, reduced child mortality by four-fold and transitioned through all stages of Gavi support. Indonesia now self-sustains its immunisation programmes, with some targeted support to ensure equitable access to high-impact vaccines, through Gavi’s flexible approach to partnering with middle-income countries. The country’s evolution to becoming a Gavi donor showcases the impact sustained investment in health can have on a country’s future.
“We welcome with deep gratitude this pledge, as well as Indonesia’s continued commitment to championing the vital importance of immunisation in building a healthier, safer and more equitable world,” said Professor José Manuel Barroso, Chair of the Gavi Board. “Indonesia’s extraordinary journey with Gavi underscores how sustainable investments in vaccines can transform lives, health systems and countries.”
“Indonesia’s contribution is a testament to the long-term impact of Gavi’s model and the strength of its partnerships,” said Dr Sania Nishtar, CEO of Gavi. “As a country that has achieved remarkable success with Gavi support, Indonesia is now paying it forward, ensuring other nations can benefit from the same life-saving interventions. We are deeply grateful for their commitment.”
To date, Gavi has helped immunise more than 1.1 billion children, saving more than 18 million lives and helping halve childhood mortality in the lower-income countries where it works. It also provides a critical foundation for global health security, helping countries prevent and respond to infectious disease emergencies.
The Alliance is currently seeking to raise at least US$ 9 billion for its next strategic period, which will aim to protect at least 500 million children and save an additional 8–9 million lives between 2026 and 2030. These efforts are projected to generate over US$ 100 billion in economic benefits for countries implementing Gavi programmes while catalysing US$ 4 billion in co-financing of immunisation from these nations.
Indonesia’s commitment comes a day after the European Union and the Bill and Melinda Gates Foundation announced they will co-host a high-level pledging meeting in support of Gavi’s replenishment efforts for Gavi 6.0. The event, which will convene leaders from government, partner organisations, vaccine manufacturers, civil society and the private sector, will be held in Brussels in the first quarter or early in the second quarter of 2025.
The news also follows the Gavi Board’s approval of a series of measures aimed at building sustainable immunisation programmes and improving vaccine access in fragile countries and settings, during a two-day meeting hosted by Indonesia.
